Skip to main content
logo
Aptevo Therapeutics Inc. (APVO)
NASDAQ: APVO · Real-Time Price · USD
1.710
-0.890 (-34.23%)
At close: Sep 3, 2026, 4:00 PM EDT
1.680
-0.030 (-1.75%)
Pre-market: Sep 4, 2026, 6:37 AM EDT

Aptevo Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
39231137
Market Cap Growth
-42.94%309.61%-36.51%-68.79%-70.52%-75.46%
Enterprise Value
-3-7-0-10-14
Last Close Price
1.719.431551.60106077.481359667.124612319.05

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
----1.36-
Forward PE
-160.84160.84160.84160.84160.84
PS Ratio
----3.493.00
PB Ratio
0.400.510.450.280.6130.34
P/TBV Ratio
0.510.510.450.280.6130.34

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
-----0.34

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.700.271.140.440.5513.75
Net Debt / Equity Ratio
-0.92-0.98-0.70-0.94-0.70-23.30
Net Debt / EBITDA Ratio
0.210.650.140.410.461.40
Net Debt / FCF Ratio
0.220.660.140.980.601.26
Asset Turnover
----0.070.22
Quick Ratio
1.893.571.402.342.891.40
Current Ratio
2.083.821.722.643.151.51
Return on Equity (ROE)
-420.34%-234.61%-284.28%-123.53%73.10%-330.24%
Return on Assets (ROA)
-111.49%-76.87%-76.06%-61.12%-39.42%-24.29%
Return on Capital Employed (ROCE)
-288.10%-124.40%-262.20%-163.90%-112.30%-98.00%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-860.17%-294.15%-1119.63%-512.92%73.80%-77.12%
FCF Yield
-822.46%-289.90%-1103.63%-345.56%-193.53%-60.69%
SEC Filings: 10-K · 10-Q